Showing 281-290 of 333 results for "".
High-Dose Ipilimumab Shows Benefits in Advanced Melanoma: Implications for Care
https://practicaldermatology.com/topics/skin-cancer-photoprotection/high-dose-ipilimumab-shows-benefits-in-advanced-melanoma-implications-for-care/20687/Although treatment is associated with a high rate of toxicity, survival benefit is extended at a higher dose.A Non-Invasive 2-Gene Molecular Assay Shows Promise in Assessment of Pigmented Lesions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-non-invasive-2-gene-molecular-assay-shows-promise-in-assessment-of-pigmented-lesions/20705/More studies are needed, but a non-invasive assay that identified melanoma gene expression could support clinical decision making.Physician Spotlight: David A. Straker, DO
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-david-a-straker-do/20758/A specialist discusses the mind/skin connection and addresses the influence of prescription medications.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20748/Practical Considerations for Treating Psoriasis: Focus on Secukinumab
https://practicaldermatology.com/topics/psoriasis/practical-considerations-for-treating-psoriasis-focus-on-secukinumab/20841/The Skinny on Non-Invasive Fat Reduction: The Case for an a la Carte Approach to Body Contouring
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-skinny-on-non-invasive-fat-reduction-the-case-for-an-a-la-carte-approach-to-body-contouring/20978/As the business of body contouring explodes, physicians—and patients—must consider the treatment options.Papa in at Valeant, J&J Acquires Neostrata, Celebrity Lip Envy
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-papa-in-at-valeant-j-j-acquires-neostrata-celebrity-lip-envy/18772/This edition of DermWireTV brings news that Joseph C. Papa has left Perrigo Company plc, a top five global over-the-counter consumer goods and pharmaceutical company, to take the helm as CEO at Valeant Pharmaceuticals. He will replace J. Micheal Pearson. Valeant also concluded its investigation arouNews
https://practicaldermatology.com/topics/general-topics/news/21339/Biologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/Advances in Cosmeceuticals and Makeup – State of the Art from the Innovators, Part II
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-cosmeceuticals-and-makeup--state-of-the-art-from-the-innovators-part-ii/21593/Experts from different arenas in cosmetic dermatology discuss current and future developments.